These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8746424)

  • 1. Central nervous system rendez-vous--canine progressive posterior paresis.
    Little PB
    Can Vet J; 1996 Jan; 37(1):55-6. PubMed ID: 8746424
    [No Abstract]   [Full Text] [Related]  

  • 2. Protozoal hepatitis associated with immunosuppressive therapy in a dog.
    Fry DR; McSporran KD; Ellis JT; Harvey C
    J Vet Intern Med; 2009; 23(2):366-8. PubMed ID: 19192151
    [No Abstract]   [Full Text] [Related]  

  • 3. What is your diagnosis? Fine-needle aspirate of ulcerative skin lesions in a dog.
    Gupta A; Stroup S; Dedeaux A; Bauer RW; Gaunt SD
    Vet Clin Pathol; 2011 Sep; 40(3):401-2. PubMed ID: 21848675
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous neosporosis during treatment of pemphigus foliaceus in a dog.
    Ordeix L; Lloret A; Fondevila D; Dubey JP; Ferrer L; Fondati A
    J Am Anim Hosp Assoc; 2002; 38(5):415-9. PubMed ID: 12220024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Scott-Moncrieff C
    J Am Anim Hosp Assoc; 2001; 37(1):11. PubMed ID: 11204471
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
    J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Elwood C; Polton G
    J Vet Intern Med; 2008; 22(5):1075. PubMed ID: 18844828
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three months of prednisolone is enough treatment for IHA].
    Haneveld JK
    Tijdschr Diergeneeskd; 2011 Sep; 136(9):654-5. PubMed ID: 21939018
    [No Abstract]   [Full Text] [Related]  

  • 11. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).
    Grundy SA; Barton C
    J Am Vet Med Assoc; 2001 Feb; 218(4):543-6. PubMed ID: 11229506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia in two dogs.
    Matus RE; Schrader LA; Leifer CE; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1985 Apr; 186(7):691-3. PubMed ID: 2580820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of cutaneous neosporosis in a dog receiving immunosuppressive therapy: molecular identification and management.
    Legnani S; Pantchev N; Forlani A; Zini E; Schares G; Balzer J; Roccabianca P; Ferri F; Zanna G
    Vet Dermatol; 2016 Feb; 27(1):49-e14. PubMed ID: 26627466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
    Swann JW; Skelly BJ
    J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of immune-mediated thrombocytopenia, possibly Evans syndrome, in a neutered Rottweiler dog.
    Apps C
    Can Vet J; 2023 Apr; 64(4):379-382. PubMed ID: 37008642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
    Goggs R
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].
    Rieder J; Mischke R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.